21st.BIO

21st.BIO's team

© 21st.BIO
Company News

21st.BIO’s Precision Fermented Whey for Animal-Free Dairy Obtains US GRAS Status

Danish fermentation upscaling partner 21st.BIO announces that it has earned self-affirmed Generally Recognized as Safe (GRAS) status for its precision fermented beta-lactoglobulin, BLG Essential+. The GRAS milestone assures that 21st. BIO’s animal-free whey is safe for human consumption, allowing its commercialization within US territory. According to the biotech company, beta-lactoglobulin, the predominant protein in milk’s whey, has garnered significant interest from producers due to its high nutritional quality and beneficial properties for food product formulation. BLG Essential+ is said to boast essential and branched-chain amino acids, offering 45% more leucine than commercially available whey protein isolates. In addition, it is tasteless, pH-stable, and heat-tolerant, making it easy to incorporate into foods, from alt-dairy to protein drinks to bakery products. Precision-fermented whey for protein suppliers Founded in …

more

21st.BIO unveils a new pilot plant facility to accelerate the impact of biotech innovations globally.

Image courtesy of 21st.BIO
Fermentation

21st.BIO Unveils Cutting-Edge Facility to Accelerate Transition Between Lab and Large-Scale Fermentation

21st.BIO, a Danish bioproduction firm offering integrated end-to-end services, has launched a new pilot facility in its Danish headquarters in Søborg to facilitate and accelerate the transition between lab and large-scale fermentation of biotech innovations.  At its new plant, 21st.BIO aims to guide and support early-stage startups or large companies in scaling the production of recombinant proteins and peptides with applications in nutrition, F&B, agriculture, biomaterials, and biopharma.   The new plant features “state-of-the-art” processing equipment with over 3000 L fermentation capacity, focusing on optimizing specific processes. It offers services from strain construction to industrial production to help customers scale more quickly in a risk-mitigated and cost-effective way. Thomas Schmidt, co-founder and CEO of 21st.BIO, commented, “In this industry, upscaling mistakes cost a lot of money and time. For …

more

Topics:

21st.BIO's team

© 21st.BIO
Manufacturing & Technology

21st.BIO Opens Access to its Large-Scale Production Platform for Animal-Free Dairy Proteins

21st.BIO, a Danish bioproduction firm offering integrated end-to-end services, announces that it is granting access to its precision fermentation technology platform to produce animal-free dairy proteins. The new service aims to offer ingredient manufacturers, from startups to leading companies, cost-effective solutions to accelerate the development of sustainable dairy proteins at a competitive cost. 21st.BIO states it has the industry’s most advanced precision fermentation technology platform for large-scale production. Its fermentation technology is partly licensed from Novonesis (a merger of Novozymes and Chr. Hansen Holding), which has developed its platform over several decades to produce food-grade ingredients. Thomas Schmidt, CEO of 21st.BIO, comments: “We founded 21st.BIO with one simple mission: to make precision fermentation technology accessible to as many companies as possible, so they can successfully take their …

more

AMSilk and 21st.BIO join forces to scale silk protein materials production.

© AMSilk
Materials

AMSilk and 21st.BIO Forge Alliance to Scale Bioproduced Spider Silk Proteins “From Kilos to Tons”

German Biotech AMSilk GmbH announces a partnership with the Danish bioproduction leader 21st.BIO, to accelerate the production of advanced bioproduced spider silk proteins to meet the growing demand for sustainable material solutions. As part of the collaboration, 21st.BIO has developed precision-fermented microorganisms that can be used to produce silk proteins on an industrial scale. According to 21st.BIO, the new strain ensures the extracellular expression of silk proteins while enabling biomanufacturing at unprecedented productivity levels, supporting higher yield, greater efficiency, and reduced production costs.  Gudrun Vogtentanz, CSO at AMSilk, shares: “Through 21st.BIO, we now have access to more efficient production strains, which are a game changer in terms of the efficiency and sustainability of our feedstock. Moving production quantities from kilos to tons brings AMSilk’s technology to the next …

more

Topics: